Beta Bionics

Beta Bionics

Growth Stage

Building a bionic pancreas to improve the lives of people with type 1 diabetes

Building a bionic pancreas to improve the lives of people with type 1 diabetes

Overview

Funding data not publicly available
Platform

Wefunder

Start Date

05/16/2016

Close Date

12/19/2016

Min. Goal
$50,000
Max. Goal
$1,000,000
Min. Investment

$100

Security Type

Equity - Common

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$100.00

Pre-Money Valuation

$100,000,000

Year Founded

2015

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Location

Boston, Massachusetts

Beta Bionics is raising funds on Wefunder. The company is building a bionic pancreas to improve the lives of people with type 1 diabetes. They have developed the iLet, a pocket-sized wearable medical device that autonomously manages blood sugar levels. They are backed by 10 years of clinical data with 6 outpatient human clinical trials already completed. Edward Damiano founded Beta Bionics in 2015. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $1 million. The campaign proceeds will be used for product development, clinical trials, headcount, and operational expenses.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-230,547

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$1,250

$0

Accounts Receivable

$0

$0

Total Assets

$5,015,954

$0

Short-Term Debt

$267,070

$0

Long-Term Debt

$0

$0

Total Liabilities

$267,070

$0

Financials as of: 05/16/2016
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Beta Bionics 08/30/2023 Self Managed - - Other Security Type Funded RegD 506(c)
Beta Bionics 03/02/2022 Self Managed - - Equity - Common Funded RegD 506(b)
Beta Bionics 07/22/2019 Self Managed - - Equity - Common Funded RegD 506(b)
Beta Bionics 12/27/2017 Self Managed - - Equity - Common Funded RegD 506(b)
Beta Bionics 12/19/2016 Wefunder $100,000,000 - Equity - Common Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Beta Bionics on Wefunder 2016
Platform: Wefunder
Security Type: Equity - Common
Valuation: $100,000,000
Price per Share: $100.00

Follow company

Follow Beta Bionics on Wefunder 2016

Buy Beta Bionics's Deal Report

Warning: according to the close date for this deal, Beta Bionics may no longer be accepting investments.

Beta Bionics Deal Report

Get KingsCrowd’s comprehensive report on Beta Bionics including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Beta Bionics is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Beta Bionics deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge